Background. Obsessive-compulsive disorder (OCD) is a major psychiatric disorder identified mostly by obsessions and compulsions. Molecular genetic and gene-expression studies focused on familial and twin cases have shown a wide variety of variant genes related to OCD.
Obsessive-compulsive disorder (OCD) is a major psychiatric disorder characterized by obsessive thoughts of an intrusive and disturbing nature, and compulsions -repetitive stereotypic behaviors usually associated with anxiety or dread. [1] [2] [3] There is considerable evidence suggesting that OCD may have a biological basis. OCD shares similar features with some neurological diseases, such as Huntington's chorea, encephalitis lethargica (von Economo's encephalitis), Parkinson's disease, Tourette syndrome, schizophrenia, Sydenham's chorea, certain epilepsy types and organic brain disorders such as those caused by trauma, ischemia and tumors. [4] [5] [6] [7] Numerous family studies, segregation analyses, twin and linkage studies have been conducted to understand the genetic and molecular mechanisms of OCD. [8] [9] [10] [11] These studies have led to a better understanding of the genetic and environmental factors leading to the development of OCD. However, the impact of DNA repair genes on OCD development has not been investigated. DNA damage resulting from alkylation, deamination and oxidative stress is mainly reversed by the base excision repair (BER) pathway to ensure genome integrity. The human oxoguanine glycosylase 1 (HOGG1), AP endonuclease 1 (APE1) and X-ray repair cross-complementing 1 (XRCC1) genes are involved in the BER pathway. HOGG1 is a BER enzyme that recognizes and excises 8-hydroxydeoxyguanine (8-oxo-dG), whereas APE1 is the rate-limiting enzyme in the BER pathway. [12] [13] [14] [15] It cleaves 50 DNA abasic sugar residues generated from ionizing radiation and environmental carcinogens. [16] [17] [18] The XRCC genes are involved in different DNA repair processes contributing to genetic stability. 19, 20 XRCC1 acts as a scaffold for other BER enzymes, while XRCC3 encodes RAD-51-like proteins, and is necessary for homologous recombination DNA repair. 21 The authors hypothesized that genetic alterations in the components of the DNA repair system could be used as a molecular marker for OCD prognosis. This study was aimed at evaluating the distribution of polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, XPG, APE1 and HOGG1 in OCD patients.
Material and methods
The study population OCD subjects were diagnosed according to the criteria in the 1994 American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM IV) and were recruited at the Psychiatric Department of Istanbul Erenkoy Psychiatric and Neurological Disorders Hospital (Turkey), which has an inpatient ward for acute psychiatric patients. All the patients' medical histories were taken upon their first admission. Assessments for the diagnosis of OCD were performed by 2 psychiatrists using cross-sectional interviews and case records. All the patients had active symptoms at the time of the study. Patients with a history of neurological or medical disorders that would affect neuropsychological function (i.e., seizures, head trauma, stroke, brain tumor, meningitis) or with a recent history of alcohol or psychoactive drug abuse were excluded. A total of 100 OCD patients were included in the study.
Normal control participants were recruited from a large medical outpatient clinic. Their demographic data, medical and psychiatric history were investigated, and subjects with a diagnosis of any DSM-IV axis I or axis II disorders were excluded. None of the control subjects had a history of medical illness, head injury, neurological disorder, psychiatric disorder or alcohol or substance abuse, and none had a family history of any psychiatric disorder. A total of 122 unrelated healthy controls were included the study.
Measurements, protocol and procedure
All the subjects were examined using a standardized interview. Assessments were done on a semi-structured socio-demographic form that required patient information regarding the demographic and personal details of the patients and informants, the patients' complaints, the history of the present illness, details of medical or surgical interventions, past history, family history, premorbid personality, physical examination details, a mental status examination, and a diagnostic formulation. The potential cases were interviewed by a psychiatrist, and their medical records were reviewed whenever relevant. Secondly, a consultant psychiatrist audited the 1 st phase results, and confirmed or rejected the diagnosis.
To minimize the effect of ethnic differences in gene frequencies, the study participants were chosen from the Turkish population living in the western region of Turkey. The study was approved by the Medical Ethics Committee of Istanbul Medical Faculty, and all the participants gave written informed consent.
Polymorphism analysis
Blood samples from all the study participants were collected in EDTA-containing tubes. Genomic DNA was extracted from peripheral whole blood using a commercially available kit according to the manufacturer's instructions (PureLink Genomic DNA Mini Kit, Thermo Fisher Scientific Inc., Waltham, USA). Polymerase chain reaction (PCR)/restriction fragment length polymorphism (RFLP) analysis was performed to detect variations in DNA repair genes APE1, HOGG1, XRCC1, XRCC3, XPD and XPG. Appropriate primers were used to amplify the subjects' corresponding gene by PCR, and the reaction products were digested using the appropriate enzyme at 37°C. The digested products were analyzed on 2% agarose gel stained with ethidium bromide, and examined under transillumination. Two observers, blind to the subjects' diagnoses, read each gel. In case of any conflict, the experiments were repeated.
Statistical analysis
The statistical analyses were performed using SPSS software (v. 11.5, SPSS Inc., Chicago, USA). Differences in the distribution of DNA repair genotypes or alleles between the patient group and the control group were tested using the χ 2 test; the data was expressed as means ± standard deviation (SD). Demographic data was compared using Student's ttest and the χ 2 test, as required. Relative risk with 95% confidence intervals (CI) was calculated as the odds ratio (OR). An OR > 1 is associated with higher odds of the outcome; an OR < 1 is associated with lower odds of the outcome; and an OR = 1 does not affect the odds of the outcome. 22 In addition to this, minor allele frequency and HardyWeinberg equilibrium were calculated by Haploview 4.2 software (The Broad Institute, Cambridge, USA). Linkage disequilibrium among DNA repair gene polymophisms was assessed using D ' and r 2 values obtained through the Haploview program. Multiple comparisons were controlled using the Bonferroni correction. P-values < 0.05 were considered statistically significant. Table 1 shows the characteristics of the patient and control groups. The controls and patients were adjusted for age, sex, smoking habit, and alcohol use (p < 0.05).
Results
The distribution of APE1, XRCC1, XRCC3, XPD, XPG and HOGG1 genotype frequencies in the OCD patients and controls is shown in Table 3 . XPG His and XPD Lys allele frequencies were significantly higher in the patients than in the controls.
Minor allele frequency (MAF) values are also given in Table 3 . With the exception of the XRCC3 Thr241Met genotype, the distribution of all allele and genotype frequencies among the patients and the controls was in accordance with Hardy-Weinberg equilibrium.
When the results were analyzed in terms of haplotype frequencies, the only significant difference between the controls and the patients was found in the haplotype with XRCC1 Arg: XPG Asp (Table 4 ). There was a weak linkage disequilibrium between the XRCC1 and XPG polymorphisms (D': 0.198, logarithm of odds (LOD): 0.33, r 2 : 0.006).
Discussion
OCD is a widespread psychiatric disorder that is characterized by disabling obsessions and/or compulsions. 24 Originally thought to be rare, OCD is now known to have a lifetime prevalence around 1-3% worldwide, making it one of the most common and serious mental conditions. [25] [26] [27] Although the exact causes of OCD are unknown, data from family studies suggests the presence of a heritable factor, and implies that genetic factors might account for around 50% of OCD symptoms. Moreover, polymorphisms of certain genes have been associated with OCD. 15, 23, 28 The present study attempted to unravel potential association between DNA repair genes and OCD. To the authors' knowledge, this is the first study focused on the potential contribution of XRCC1, XRCC3, XPD, XPG, APE1 and HOGG1 genotypes to OCD pathogenesis.
The study found that certain XPD gene polymorphisms might have a facilitating or protective role in OCD development. These results not only suggest that DNA repair mechanisms somehow influence the neuronal pathways controlling behaviors, but also lend further support to a biological basis of OCD.
Exposure to certain chemicals such as hydrocarbons, aryl amines and nitrosamines might result in the formation of reactive oxygen species as by-products, which might ultimately affect DNA functions. DNA repair mechanisms are thus of paramount importance in reversing alterations to DNA and providing unmutated DNA during the replication process. More than a hundred genes are known to participate in DNA repair mechanisms. [29] [30] [31] Biological models of OCD propose anomalies in the dopamine and serotonin pathways of the brain. 32 At least in some patients, OCD might plausibly be the end result of mesocortical pathway dysfunction caused by a variety of factors such as trauma, infections and autoimmunity. Increased generation of reactive oxygen species as a result of impaired DNA repair mechanisms might be rendering the dopaminergic mesocortical pathway more susceptible to these environmental factors. Recent findings on the association between DNA repair gene polymorphisms and Parkinson's disease, which is also related to dopaminergic pathways, support this hypothesis. 33 It is also possible that XPD genes have some yet unknown function in dopamine and/or serotonin metabolism. According to human brain tissue studies, DNA damage has been found at increasingly high levels in nervous system disorders, adding to the importance of the present study to research investigating OCD mechanisms. [34] [35] [36] [37] [38] It is possible to say that there might be an important relationship between the DNA repair system and neurodegeneration. This area should be investigated further in large-scale studies to focus specifically on identifying which repair system is related to the disease mechanism.
Conclusions
The findings of the current study suggest that certain XPD genotypes are associated with the development of OCD. Further studies with larger sample groups are necessary to clarify the significance of these gene variants. Moreover, the mechanisms by which these genes contribute to OCD pathogenesis need to be clarified.
